每经AI快讯，俊裕地基(01757.HK)复牌后涨近20%，截至发稿，涨14.12%，报0.485港元，成交额624.79 万港元。 ...

完成已于买卖协议签署后即时作实。紧随完成后，要约人及其一致行动人士拥有9亿股股份，占本公司 已发行股本总额的75%，而卖方不再为股东。 紧随完成后，要约人及其一致行动人士拥有9亿股股份，占本公司已发行股本总额的75%。根据收购守 则第26.1条，要约人因此须就所有已发行股份(除要约人及其一致行动人士已拥有或同意将予收购的股 份外)作出强制性无条件现金要约。每股要约股份的要约价格现金0.089港元，较股份于最后交易日在联 交所所报的收市价每股0.425港元折让约79.06%。 智通财经APP获悉，俊裕地基(01757)复牌后涨近20%，截至发稿，涨14.12%，报0.485港元，成交额 624.79万港元。 消息面上，俊裕地基及要约人中国创投控股有限公司联合公布，于2025年10月15日，卖方Oriental Castle Group Limited、担保人及要约人订立买卖协议，卖方同意出售及要约人同意购买待售股份，即9 亿股股份，相当于本公司于本联合公告日期已发行股本总额的75%，总现金代价为8000万港元(即每股 待售股份0.089港元)，已由要约人透过提取卓导向其授出的待售股份融资悉数结付。 ...

完成已于买卖协议签署后即时作实。紧随完成后，要约人及其一致行动人士拥有9亿股股份，占本公司 已发行股本总额的75%，而卖方不再为股东。 紧随完成后，要约人及其一致行动人士拥有9亿股股份，占本公司已发行股本总额的75%。根据收购守 则第26.1条，要约人因此须就所有已发行股份(除要约人及其一致行动人士已拥有或同意将予收购的股 份外)作出强制性无条件现金要约。每股要约股份的要约价格现金0.089港元，较股份于最后交易日在联 交所所报的收市价每股0.425港元折让约79.06%。 俊裕地基(01757)复牌后涨近20%，截至发稿，涨14.12%，报0.485港元，成交额624.79万港元。 消息面上，俊裕地基及要约人中国创投控股有限公司联合公布，于2025年10月15日，卖方Oriental Castle Group Limited、担保人及要约人订立买卖协议，卖方同意出售及要约人同意购买待售股份，即9 亿股股份，相当于本公司于本联合公告日期已发行股本总额的75%，总现金代价为8000万港元(即每股 待售股份0.089港元)，已由要约人透过提取卓导向其授出的待售股份融资悉数结付。 ...

Core Viewpoint - Junyu Foundation (01757.HK) announced that its shares will resume trading today, October 24, 2025 [1] Group 1 - The company's shares will start trading again at 9:00 AM [1]

Core Viewpoint - China Venture Capital Holdings Limited has acquired a 75% stake in Junyu Foundation for a total consideration of HKD 80 million, indicating a significant consolidation in the market [1] Group 1: Acquisition Details - The acquisition involves the purchase of 900 million shares of Junyu Foundation at a price of HKD 0.089 per share [1] - The offer price represents a discount of approximately 79.06% compared to the closing price on the last trading day [1] - Trading of Junyu Foundation shares will resume on the Hong Kong Stock Exchange on October 24, 2025, at 9:00 AM [1]

Major Events - Minglue Technology (02718) plans to offer 7.219 million Class A shares globally from October 23 to October 28, with cornerstone subscriptions amounting to $59 million [1] - Wisco Properties (00230) received a privatization offer from Wisco Hong Kong at a premium of approximately 104.08%, with trading resuming on October 24 [1] - Junyu Foundation (01757) was acquired by China Venture Capital Holdings for 75% of its shares at a discount of about 79.06%, with trading resuming on October 24 [1] - Kangda Foods (00834) was acquired by Gaosi Shi for approximately 54.69% of the company’s shares at a premium of about 16.23%, with trading resuming on October 24 [1] - Hutchison China MediTech (00013) presented data on HMPL-A251 at the AACR-NCI-EORTC International Conference on Molecular Targeted and Cancer Therapeutics [1] - Giant Bio (02367) received a medical device registration certificate for its Type I α1 collagen lyophilized fiber product [1] - Yiming Anke-B (01541) completed the first patient dosing in the Phase IB/II clinical trial of IMM2510 combined with IMM01 [1] - Heng Rui Medicine (01276) received approval to conduct clinical trials for injection of Rikan Trastuzumab [1] - Hansoh Pharmaceutical (03692) had its application for HS-10365 capsule marketing approval accepted by the National Medical Products Administration [1] - Baixin An-B (02185) completed market access and the first commercial surgery for the IBERIS® RDN system in Switzerland [1] - Haotian International Construction Investment (01341) purchased a total of 646 units of Ethereum as of October 23 [1] Share Buybacks/Reductions - Cornerstone Pharmaceuticals-B (02616) saw CEO Yang Jianxin and senior management purchase an additional 1 million shares [2] - Midea Group (00300) repurchased 1.3434 million A shares for approximately 99.998 million yuan on October 23 [2] - China Communications Construction (01800) repurchased 119.45 million A shares for approximately 10.5994 million yuan on October 23 [2] - Mengniu Dairy (02319) repurchased 700,000 shares for approximately 10.0692 million HKD on October 23 [2] - Lianlian Digital (02598) spent about 7.5555 million HKD to repurchase 967,000 shares on October 23 [2] - Lianyi Rong Technology-W (09959) repurchased 2.47 million shares for approximately 7.4137 million HKD on October 23 [2] - Heng Rui Medicine (01276) repurchased 97,500 A shares for approximately 6.2808 million yuan on October 23 [2] - Gushengtang (02273) repurchased 19,860 shares for approximately 5.8634 million HKD on October 23 [2] Operating Performance - Ping An Good Doctor (01833) reported total revenue of approximately 3.725 billion yuan for the first three quarters, a year-on-year increase of 13.6%, and plans to continue expanding AI technology to enhance medical service efficiency and quality [2] - Sands China Ltd. (01928) reported a 7.5% year-on-year increase in net revenue to $1.9 billion for the third quarter [2] - Livzon Pharmaceutical (01513) announced a net profit attributable to shareholders of 1.754 billion yuan for the first three quarters, a year-on-year increase of 4.86% [2] - China Railway Construction (01186) signed new contracts totaling 1.518765 trillion yuan in the first three quarters, a year-on-year increase of 3.08% [2] - Prada (01913) reported net revenue of 4.07 billion euros for the first three quarters, a year-on-year increase of 9% [2] Additional Performance Metrics - Baio Family Interactive (02100) reported 10.2 million active accounts in the third quarter, a year-on-year increase of 37.8% [3] - Anton Oilfield Services (03337) secured new orders worth 1.273 billion yuan in the third quarter [3]

Group 1 - The controlling shareholder Oriental Castle Group Limited has reached a share transfer agreement with China Venture Capital Holdings Limited to sell 75% of the company's shares for HKD 80 million [1] - The purchase price is set at HKD 0.089 per share, representing a significant discount of 79.06% compared to the closing price before the suspension [1] - Following the completion of the transaction, the buyer and its concert parties will own 900 million shares, accounting for 75% of the total issued share capital of the company [1] Group 2 - A mandatory general offer will be made at the same price of HKD 0.089 per share, which also reflects a 79.06% discount from the closing price on October 15 [1] - The buyer, China Venture Capital Holdings Limited, is a company registered in the British Virgin Islands [1] - The company's shares are set to resume trading on October 24 [1]

Core Viewpoint - Junyu Foundation (01757) and the offeror China Venture Capital Holdings Limited announced a sale agreement for 900 million shares, representing 75% of the company's issued share capital, for a total cash consideration of HKD 80 million, equating to HKD 0.089 per share, which is significantly lower than the last trading price [1][1][1] Group 1 - The seller, Oriental Castle Group Limited, has agreed to sell 900 million shares to the offeror, which will be financed through the extraction of the offered shares [1] - Following the completion of the sale, the offeror and its concert parties will own 75% of the company's issued share capital, and the seller will no longer be a shareholder [1] - According to the takeover code, the offeror is required to make a mandatory unconditional cash offer for all issued shares at the same price of HKD 0.089 per share, which represents a discount of approximately 79.06% compared to the last closing price of HKD 0.425 [1][1][1] Group 2 - The company's shares are set to resume trading on the Stock Exchange at 9:00 AM on October 24, 2025 [1]

Core Viewpoint - Junyu Foundation (01757) and the offeror, China Venture Capital Holdings Limited, announced a sale agreement for 900 million shares, representing 75% of the company's total issued share capital, for a total cash consideration of HKD 80 million, equating to HKD 0.089 per share, which is a significant discount compared to the last trading price [1] Group 1 - The seller, Oriental Castle Group Limited, has agreed to sell 900 million shares to the offeror, which will be financed through the extraction of the offered shares [1] - Upon completion of the agreement, the offeror and its concert parties will own 900 million shares, accounting for 75% of the company's total issued share capital, while the seller will no longer be a shareholder [1] - According to Rule 26.1 of the Takeovers Code, the offeror is required to make a mandatory unconditional cash offer for all issued shares, excluding those already owned or agreed to be acquired by the offeror and its concert parties, at a price of HKD 0.089 per share, representing a discount of approximately 79.06% from the last closing price of HKD 0.425 [1] Group 2 - The company has applied for the resumption of trading of its shares on the Stock Exchange starting from 9:00 AM on October 24, 2025 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本聯合公告之內容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 聯合公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承 擔 任 何 責 任。 本 聯 合 公 告 僅 供 參 考，並 不 構 成 收 購、購 買 或 認 購 俊 裕 地 基 集 團 有 限 公 司 證 券 之 邀 請 或 要 約 或 構 成 其 一 部 分，或 於 任 何 司 法 權 區 招 攬 任 何 表 決 權 或 批 准，亦 不 得 在 與 適 用 法 律 或 法 規 相 抵 觸 之 情 況 下 於 任 何 司 法 權 區 出 售、發 行 或 轉 讓 俊 裕 地 基 集 團 有 限 公 司 證 券。倘 此 舉 屬 違 反 當 地 有 關 法 律，本 聯 合 公 告 不 會 於 或 向 任 何 該 等 司 法 權 區 發 佈、刊 發 或 派 發。 China VC Holdings Limited 中國創投控股有限公司 （於 英 屬 處 女 群 島 註 冊 成 立 的 有 限 公 司） Afuent Fo ...